MediciNova Receives U.S. Patent Office Notice Of Allowance Covering The Use Of Ibudilast In The Treatment Of Glioblastoma
MediciNova Inc MNOV
$1.34
▲ +0.00%
(+$0.00)
Open
$1.35
Prev Close
$1.34
Day Range
$1.32 – $1.35
52W Range
$1.17 – $1.96
Market Cap
$64.97M
Beta
0.64
EPS (TTM)
$-0.24
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2006-12-01 |
| Shares Out. | 49,220,000 |
| Website | medicinova.com/ ↗ |
| Phone | 18583731500 |
MediciNova Inc is a publicly traded company under the ticker symbol MNOV on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
9 analysts (2026-06-01)